Mark J Suto

USPTO Granted Patents = 34 (Patent Applications = 14)

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 13)

Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 91(Granted Patents)

Location History:

La Jolla, CA (US) (2005 - 2007)
Chapel Hill, NC (US) (2009 - 2015)
Birmingham, AL (US) (2015 - 2019)
Homewood, AL (US) (2020 - 2024)

Company Filing History:

21 out of 203

Southern Research Institute

patents

11 out of 580

The Uab Research Foundation

The United States Government As Represented by the Department of Veterans Affairs

Bristol-myers Squibb Compnay

patents

8. 1 out of 1

Southern Reserach Institute

patent

where one patent can have more than one assignee

Years Active: 2005-2025

Loading Chart...

34 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12215108 - Development of potential antidotes for arsenicals (2025-02-04),

2. 12208112 - Composition for treating blood cancer using 4'-thio-5-Aza-2′-deoxycytidine and uses thereof (2025-01-28),

3. 12098216 - Modulators of programmed death-ligand-1 and/or programmed death-ligand-2 (2024-09-24),

4. 11945781 - Compounds for the treatment of acute and chronic kidney disease (2024-04-02),

5. 11905258 - 2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative diseases (2024-02-20),

6. 11753374 - Compounds for the treatment of acute and chronic kidney disease (2023-09-12),

7. 11752153 - Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors (2023-09-12),

8. 11718593 - 2,5-aryl-thiazole analogs for the treatment of neurodegenerative diseases (2023-08-08),

9. 11623918 - Compounds for the treatment of acute and chronic kidney disease (2023-04-11),

10. 11524010 - Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors (2022-12-13),

11. 11505531 - Piperazine-2,5-diones as TGF-beta inhibitors (2022-11-22),

12. 11472781 - 2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative diseases (2022-10-18),

13. 11447472 - Polymorophs of 5-aza-4'-thio-2′-deoxycytidine (2022-09-20),

14. 11103508 - Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors (2021-08-31),

15. 11066357 - Benzoannulene derivatives as antiviral agents (2021-07-20),

Title: The Innovative Journey of Mark J Suto

Introduction: Mark J Suto, a talented inventor based in Homewood, Alabama, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Mark J Suto's latest patents include a cutting-edge software application for enhancing cybersecurity measures in financial institutions and a revolutionary medical device designed to improve patient care in hospitals.

Career Highlights: With over two decades of experience in the technology sector, Mark J Suto has a proven track record of developing innovative solutions that address complex challenges. He has worked for leading tech companies, where he spearheaded research and development projects that have resulted in multiple successful patent applications.

Collaborations: Throughout his career, Mark J Suto has collaborated with top researchers, engineers, and scientists to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Mark J Suto's passion for innovation and his dedication to pushing the boundaries of technology have established him as a respected figure in the inventor community. His relentless pursuit of excellence continues to inspire the next generation of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.